• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

• 페이스북 공유
• 트위터 공유
• 

Depression Treatment Advancements

While effective treatments for depression are available Researchers are developing new treatments for depression, browse around this site, and better ways to treat depression. This special Research in Context will explore some of the advancements in depression treatment.

Psychotherapy can help alleviate depression symptoms by educating the person how to manage negative feelings and thoughts. Talk therapy can be done in a one-on-one session with a mental health professional or in a group.

Precision mental healthcare

The term "precision" refers to the ability to bring more precision or precision to prevention, diagnosis and treatment methods. For mental health, this means various approaches ranging from psychotherapy to medications. Many of these strategies focus on the symptoms of the disorder rather than its root causes. This can lead treatments that only reduce symptoms, but not address the underlying causes of mental illness.

The precision of mental health is rapidly advancing. It's similar to the method taken in other areas which includes continuous monitoring of key indicators (e.g. fever or blood pressure) into the clinical practice. It also involves combining different data sets and applying machine-learning to assist physicians recognize the unique requirements of each patient and to develop more effective treatments.

One example of precision psychiatry involves using EEG to determine brain activity and help doctors assess a person's ability to engage in cognitive behavior therapy. Another example is a novel class of drugs called NMDA receptor antagonists. These could block the glutamate neurotransmitter from reaching certain brain cells, and thus reduce symptoms of mild depression treatments. Pharmacogenetic testing can also be used to determine interactions between drugs and genes, as well as to avoid negative effects.

Many companies are also exploring digital precision medicine, which makes use of objective digital technology to monitor patients remotely and collect real-time information that helps guide their care. For instance, one company is using artificial intelligence to monitor compliance and optimize dosages for patients suffering from depression. These types of solutions are likely to dramatically increase the accessibility and effectiveness of mental health services and increase compliance to treatment.

Digital precision psychiatry in particular it is a way to help people suffering from mental illness overcome barriers to treatment, especially those who work. Johnson & Johnson, for example, is partnering with organizations in Singapore to help facilitate the reintegration of workers recovering from depression back into their jobs. This will allow them to keep their jobs, which is essential for mental health recovery.

Medication

Many people who suffer from depression discover that medication can alleviate their symptoms, particularly those who are suffering from extreme or debilitating symptoms. Antidepressants restore the balance of neurotransmitters within the brain, which are chemical messengers that regulate mood and emotions. Most antidepressants today target one of these neurotransmitters by increasing levels of serotonin. Selective serotonin reuptake inhibitors (SSRIs), like Prozac and Zoloft increase the amount of serotonin in the brain. The SNRIs like Cymbalta, Effexor and Cymbalta target both dopamine and norepinephrine. Monoamine oxidase inhibitors like Wellbutrin target only dopamine and norepinephrine.

Most doctors prescribe antidepressants to combat depression as a primary treatment, along with talk therapy. Some of these therapies include cognitive behavioural therapy, which helps improve thoughts and feelings by educating specific skills or psychotherapy for interpersonal relations which is focused on improving relationships. Other therapies, like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) have also been proved to be effective in treating depression.

Unfortunately, some people do not respond to the first medication prescribed by doctors. Up to one-third of people suffering from depression do not feel relief from the initial medication they take and 40% of people who start taking antidepressants stop them after three months. The good news is that research has helped doctors predict the type of medication that will be most effective for each individual, utilizing blood or MRI tests to determine which receptors are the most affected by the depression.

The way we treat depression has improved over the last few years with a wider range of options and higher dosages that help reduce negative effects. For instance, newer antidepressants such as esketamine (Spravato), the brexanolone (Auvelity) and nefazodone (Sertraline) are designed to rapidly reduce depression symptoms by targeting glutamate activity in the brain.

Clinical trials are underway on other drugs that could alter the way they are used. A drug called vorapaxar, which is currently being tested in humans, targets a distinct part of the brain associated with depression by blocking NMDA receptors. It is expected to be available by 2024. The combination of ketamine and bupropion also has shown potential. It could be more effective in treating treatment-resistant depression.

Psychotherapy

Psychiatric researchers have been able to identify certain factors that contribute to depression, for instance, deficiency in the neurotransmitters serotonin and norepinephrine. These chemicals play a vital role in controlling mood emotions, moods, and overall brain function. Medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors are the main shock treatment for depression options. They can help alleviate many of depression-related symptoms that include depressed moods and fatigue, and also increase appetite, sleep and energy levels. They can also cause negative side effects, and could make them unsuitable for certain people.

Psychotherapy can be used to tackle the causes of depression and assist people cope better. Cognitive behavioral therapy and ketonamine therapy are two forms of therapy that have been shown to decrease depression symptoms. In addition, psychotherapy can help people develop a more healthy coping style and reduce stressors. Cost, scheduling limitations and a shortage of mental health professionals can restrict access to psychotherapy. Telehealth services have improved access for many people.

Finding the right treatment combination is essential to overcome depression. Medication alone may not be enough to relieve all of your symptoms. It may take between 6 and 12 weeks before you are able to tell if a drug is working. There are a variety of nonpharmacologic treatment options, including transcranial magnetic stimulation that is repeated and vagus nervous stimulation. These treatments employ electromagnetic fields to stimulate the brain's natural chemistry and improve mood.

It's important to collaborate closely with your healthcare provider, whether you're looking to try therapy or medication. Discuss your thoughts and feelings about the risks and potential side consequences that are associated with each. Find a service that will meet your needs if you are having trouble building trust with your doctor or therapist. A service that provides a trial period free of charge can also be a good option, as it offers you the chance to try out different approaches before committing. You'll eventually find the best treatment for you and makes you feel and look your most at your best.

Brain stimulation

In just a few short years scientists have found new ways to target specific brain regions and alter their functions quickly. These techniques can also be used to treat physical ailments as well as certain mental disorders.

rTMS is a technique which uses electromagnetic pulses to stimulate brain activity. It's similar to the magnetic impulses that are used in an MRI however, it's not strong enough to trigger seizures. The technique works by stimulating a precise area of the brain with a painless magnet. The pulsations alter the way that brain signals are processed, making it easier for you to feel better. The therapy can take as little as 3.5 minutes and won't interfere with your daily activities. You may experience a slight headache afterward.

Another option is to implant electrodes in the brain to send painful electric zaps. This treatment is also known as deep transcranial magnetic stimulation (deep TMS), and it's been used for OCD and to stop smoking. It's still being researched for depression, but early studies suggest it can reduce depressive symptoms in some people. The mechanism behind this treatment isn't completely clear, but it seems to work by altering the balance of certain neurotransmitters.

Other types of noninvasive brain stimulation are advancing as well. In a recent study, patients with severe depression and intolerance to antidepressants responded well to a treatment using magnetics called SAINT. It's personalized to each patient's brain anatomy and relies on high-dose patterns of magnetic pulses. The treatment can be delivered within a couple of hours, while previous treatments required daily sessions over weeks or months.

The researchers utilized fMRI to locate exactly the region of the brain being stimulated in every patient. They also examined the small differences in the way that the brain's different regions activated, which allowed them to determine the directional flow of signals. They discovered that in depressed people the brain's anterior cingulate cortex sent signals to an area known as the subgenual cingulate cortex. These messages were often not directed correctly. The more severe depression treatment the depression the more signals were sent in the wrong direction.